Friedreich Ataxia: Multidisciplinary Clinical Care

References

• Clay A, Hearle P, Schadt K, Lynch DR. New developments in pharmacotherapy for Friedreich ataxia. Expert Opin Pharmacother. 2019;20(15):1855–1867. doi:10.1080/14656566.2019.1639671
   PubMed Web of Science ®Google Scholar
• Strawser C, Schadt K, Hauser L, et al. Pharmacological therapeutics in Friedreich ataxia: the present state. Expert Rev Neurother. 2017;17(9):895–907. doi:10.1080/14737175.2017.1356721
   PubMed Web of Science ®Google Scholar
• Strawser CJ, Schadt KA, Lynch DR. Therapeutic approaches for the treatment of Friedreich’s ataxia. Expert Rev Neurother. 2014;14(8):949–957. doi:10.1586/14737175.2014.939173
   PubMed Web of Science ®Google Scholar
• Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256(Suppl 1):3–8. doi:10.1007/s00415-009-1002-3
   PubMed Web of Science ®Google Scholar
• Pandolfo M. Friedreich ataxia. Handb Clin Neurol. 2012;103:275–294.
   PubMedGoogle Scholar
• Chua K, Tan CY, Chen Z, et al. Long-term follow-up of pulmonary function and scoliosis in patients with duchenne’s muscular dystrophy and spinal muscular atrophy. J Pediatr Orthop. 2016;36(1):63–69. doi:10.1097/BPO.0000000000000396
   Web of Science ®Google Scholar
• Bureau MA, Ngassam P, Lemieux B, Trias A. Pulmonary function studies in Friedreich’s ataxia. Can J Neurol Sci. 1976;3(4):343–347. doi:10.1017/S0317167100025579
   Google Scholar
• Mercuri E, Finkel RS, Munotni F, et al. Diagnosis and management of Spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopaedic and nutritional care. Neuromuscular Disord. 2018;28:103–115. doi:10.1016/j.nmd.2017.11.005
   PubMed Web of Science ®Google Scholar
• Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251–267. doi:10.1016/S1474-4422(18)30024-3
   PubMed Web of Science ®Google Scholar
• Kuo SH. Ataxia. Continuum (Minneap Minn). 2019;25(4):1036–1054. doi:10.1212/CON.0000000000000753
   Google Scholar
• Stolle CA, Frackelton EC, McCallum J, et al. Novel, complex interruptions of the GAA repeat in small, expanded alleles of two affected siblings with late-onset Friedreich ataxia. Mov Disord. 2008;23(9):1303–1306. doi:10.1002/mds.22012
   PubMed Web of Science ®Google Scholar
• McDaniel DO, Keats B, Vedanarayanan VV, Subramony SH. Sequence variation in GAA repeat expansions may cause differential phenotype display in Friedreich’s ataxia. Mov Disord. 2001;16(6):1153–1158. doi:10.1002/mds.1210
   PubMed Web of Science ®Google Scholar
• Tsou AY, Paulsen EK, Lagedrost SJ, et al. Mortality in Friedreich ataxia. J Neurol Sci. 2011;307(1–2):46–49. doi:10.1016/j.jns.2011.05.023
   PubMed Web of Science ®Google Scholar
• Marty B, Naeije G, Bourguignon M, et al. Evidence for genetically determined degeneration of proprioceptive tracts in Friedreich ataxia. Neurology. 2019;93(2):e116–e124. doi:10.1212/WNL.0000000000007750
   PubMed Web of Science ®Google Scholar
• Lynch DR, Deutsch EC, Wilson RB, Tennekoon G. Unanswered questions in Friedreich ataxia. J Child Neurol. 2012;27(9):1223–1229. doi:10.1177/0883073812453498
   PubMed Web of Science ®Google Scholar
• Naeije G, Bourguignon M, Wens V, et al. Electrophysiological evidence for limited progression of the proprioceptive impairment in Friedreich ataxia. Clin Neurophysiol. 2020;131(2):574–576. doi:10.1016/j.clinph.2019.10.021
   Web of Science ®Google Scholar
• Babady NE, Carelle N, Wells RD, et al. Advancements in the pathophysiology of Friedreich’s ataxia and new prospects for treatments. Mol Genet Metab. 2007;92(1–2):23–35. doi:10.1016/j.ymgme.2007.05.009
   PubMed Web of Science ®Google Scholar
• Campuzano V, Montermini L, Moltò MD, et al. Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271(5254):1423–1427. doi:10.1126/science.271.5254.1423
   PubMed Web of Science ®Google Scholar
• Dürr A, Cossee M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med. 1996;335(16):1169–1175. doi:10.1056/NEJM199610173351601
   PubMed Web of Science ®Google Scholar
• Galea CA, Huq A, Lockhart PJ, et al. Compound heterozygous FXN mutations and clinical outcome in Friedreich ataxia. Ann Neurol. 2016;79(3):485–495. doi:10.1002/ana.24595
   PubMed Web of Science ®Google Scholar
• Cossée M, Dürr A, Schmitt M, et al. Friedreich’s ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol. 1999;45(2):200–206. doi:10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Anheim M, Mariani LL, Calvas P, et al. Exonic deletions of FXN and early-onset Friedreich ataxia. Arch Neurol. 2012;69(7):912–916. doi:10.1001/archneurol.2011.834
   Google Scholar
• Puccio H, Koenig M. Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Genet. 2000;9(6):887–892. doi:10.1093/hmg/9.6.887
   PubMed Web of Science ®Google Scholar
• Rodden LN, Chutake YK, Gilliam K, et al. Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia. Hum Mol Genet. 2021;29(23):3818–3829. doi:10.1093/hmg/ddaa267
   PubMed Web of Science ®Google Scholar
• Lazaropoulos M, Dong Y, Clark E, et al. Frataxin levels in peripheral tissue in Friedreich ataxia. Ann Clin Transl Neurol. 2015;2(8):831–842. doi:10.1002/acn3.225
   PubMed Web of Science ®Google Scholar
• Campuzano V, Montermini L, Lutz Y, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 1997;6(11):1771–1780. doi:10.1093/hmg/6.11.1771
   PubMed Web of Science ®Google Scholar
• Candayan A, Yunisova G, Çakar A, et al. The first biallelic missense mutation in the FXN gene in a consanguineous Turkish family with Charcot-Marie-Tooth-like phenotype. Neurogenetics. 2020;21(1):73–78. doi:10.1007/s10048-019-00594-1
   Web of Science ®Google Scholar
• Patel M, Isaacs CJ, Seyer L, et al. Progression of Friedreich ataxia: quantitative characterization over 5 years. Ann Clin Transl Neurol. 2016;3(9):684–694. doi:10.1002/acn3.332
   PubMed Web of Science ®Google Scholar
• Harding IH, Lynch DR, Koeppen AH, Pandolfo M. Central nervous system therapeutic targets in Friedreich ataxia. Hum Gene Ther. 2020;31(23–24):1226–1236. doi:10.1089/hum.2020.264
   PubMed Web of Science ®Google Scholar
• Koeppen AH, Becker AB, Qian J, Gelman BB, Mazurkiewicz JE. Friedreich ataxia: developmental failure of the dorsal root entry zone. J Neuropathol Exp Neurol. 2017;76(11):969–977. doi:10.1093/jnen/nlx087
   PubMed Web of Science ®Google Scholar
• Koeppen AH, Becker AB, Qian J, Feustel PJ. Friedreich ataxia: hypoplasia of spinal cord and dorsal root ganglia. J Neuropathol Exp Neurol. 2017;76(2):101–108. doi:10.1093/jnen/nlw111
   PubMed Web of Science ®Google Scholar
• Koeppen AH, Mazurkiewicz JE. Friedreich ataxia: neuropathology revised. J Neuropathol Exp Neurol. 2013;72(2):78–90. doi:10.1097/NEN.0b013e31827e5762
   PubMed Web of Science ®Google Scholar
• Koeppen AH, Davis AN, Morral JA. The cerebellar component of Friedreich’s ataxia. Acta Neuropathol. 2011;122(3):323–330. doi:10.1007/s00401-011-0844-9
   Web of Science ®Google Scholar
• Rummey C, Farmer JM, Lynch DR. Predictors of loss of ambulation in Friedreich’s ataxia. EClinicalMedicine. 2020;18:100213. doi:10.1016/j.eclinm.2019.11.006
   Google Scholar
• DeBrosse C, Nanga RPR, Wilson N, et al. Muscle oxidative phosphorylation quantitation using creatine chemical exchange saturation transfer (CrCEST) MRI in mitochondrial disorders. JCI Insight. 2016;1(18):e88207. doi:10.1172/jci.insight.88207
   Web of Science ®Google Scholar
• Rance G, Fava R, Baldock H, et al. Speech perception ability in individuals with Friedreich ataxia. Brain. 2008;131(8):2002–2012. doi:10.1093/brain/awn104
   Web of Science ®Google Scholar
• Seyer LA, Galetta K, Wilson J, et al. Analysis of the visual system in Friedreich ataxia. J Neurol. 2013;260(9):2362–2369. doi:10.1007/s00415-013-6978-z
   PubMed Web of Science ®Google Scholar
• Afsharian P, Nolan-Kenney R, Lynch AE, Balcer LJ, Lynch DR. Correlation of visual quality of life with clinical and visual status in Friedreich ataxia. J Neuroophthalmol. 2020;40(2):213–217. doi:10.1097/WNO.0000000000000878
   Web of Science ®Google Scholar
• Hamedani AG, Hauser LA, Perlman S, et al. Longitudinal analysis of contrast acuity in Friedreich ataxia. Neurol Genet. 2018;4(4):e250. doi:10.1212/NXG.0000000000000250
   PubMed Web of Science ®Google Scholar
• Corben LA, Klopper F, Stagnitti M, et al. Measuring Inhibition and Cognitive Flexibility in Friedreich Ataxia. Cerebellum. 2017;16(4):757–763. doi:10.1007/s12311-017-0848-7
   PubMed Web of Science ®Google Scholar
• Hernández-Torres A, Montón F, Hess Medler S, de Nóbrega É, Nieto A. Longitudinal study of cognitive functioning in Friedreich’s ataxia. J Int Neuropsychol Soc. 2021;27(4):343–350. doi:10.1017/S1355617720000958
   Web of Science ®Google Scholar
• Naeije G, Rai M, Allaerts N, Sjogard M, De Tiège X, Pandolfo M. Cerebellar cognitive disorder parallels cerebellar motor symptoms in Friedreich ataxia. Ann Clin Transl Neurol. 2020;7(6):1050–1054. doi:10.1002/acn3.51079
   Web of Science ®Google Scholar
• Musegante AF, Almeida PN, Monteiro RT, Barroso U. Urinary symptoms and urodynamic findings in patients with Friedreich’s ataxia. Int Braz J Urol. 2013;39(6):867–874. doi:10.1590/S1677-5538.IBJU.2013.06.14
   Web of Science ®Google Scholar
• Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG. Management and therapy for cardiomyopathy in Friedreich’s ataxia. Expert Rev Cardiovasc Ther. 2012;10(6):767–777. doi:10.1586/erc.12.57
   PubMedGoogle Scholar
• Schadt KA, Friedman LS, Regner SR, Mark GE, Lynch DR, Lin KY. Cross-sectional analysis of electrocardiograms in a large heterogeneous cohort of Friedreich ataxia subjects. J Child Neurol. 2012;27(9):1187–1192. doi:10.1177/0883073812448461
   PubMed Web of Science ®Google Scholar
• Friedman LS, Schadt KA, Regner SR, et al. Elevation of serum cardiac troponin I in a cross-sectional cohort of asymptomatic subjects with Friedreich ataxia. Int J Cardiol. 2013;167(4):1622–1624. doi:10.1016/j.ijcard.2012.04.159
   Web of Science ®Google Scholar
• Dedobbeleer C, Rai M, Donal E, Pandolfo M, Unger P. Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich’s ataxia. Eur Heart J Cardiovasc Imaging. 2012;13(4):346–352. doi:10.1093/ejechocard/jer267
   Web of Science ®Google Scholar
• Isnard R, Kalotka H, Dürr A, et al. Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich’s ataxia. Circulation. 1997;95(9):2247–2249. doi:10.1161/01.CIR.95.9.2247
   Web of Science ®Google Scholar
• Koeppen AH, Ramirez RL, Becker AB, et al. The pathogenesis of cardiomyopathy in Friedreich ataxia. PLoS One. 2015;10(3):e0116396. doi:10.1371/journal.pone.0116396
   PubMed Web of Science ®Google Scholar
• Pousset F, Legrand L, Monin ML, et al. A 22-year follow-up study of long-term cardiac outcome and predictors of survival in Friedreich ataxia. JAMA Neurol. 2015;72(11):1334–1341. doi:10.1001/jamaneurol.2015.1855
   PubMed Web of Science ®Google Scholar
• Writing Committee M; Yancy CW, Jessup M, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327. doi:10.1161/CIR.0b013e31829e8776.
   Web of Science ®Google Scholar
• Writing Committee M; Yancy CW, Jessup M, Jessup M, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016;134(13):e282–293. doi:10.1161/CIR.0000000000000435.
   Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137–e161. doi:10.1161/CIR.0000000000000509
   PubMed Web of Science ®Google Scholar
• Feingold B, Mahle WT, Auerbach S, et al. Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association. Circulation. 2017;136(13):e200–e231. doi:10.1161/CIR.0000000000000526
   Web of Science ®Google Scholar
• Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2020;142(25):e533–e557. doi:10.1161/CIR.0000000000000938
   PubMed Web of Science ®Google Scholar
• Ivak P, Zumrova A, Netuka I. Friedreich’s ataxia and advanced heart failure: an ethical conundrum in decision-making. J Heart Lung Transplant. 2016;35(9):1144–1145. doi:10.1016/j.healun.2016.06.021
   PubMed Web of Science ®Google Scholar
• Yoda M, El-Banayosy A, Arusoglu L, Tendrich G, Minami K, Korfer R. Permanent use of a ventricle assist device for dilated cardiomyopathy in Friedreich’s ataxia. J Heart Lung Transplant. 2006;25(2):251–252. doi:10.1016/j.healun.2005.04.020
   Web of Science ®Google Scholar
• McCormick A, Shinnick J, Schadt K, et al. Cardiac transplantation in Friedreich ataxia: extended follow-up. J Neurol Sci. 2017;375:471–473. doi:10.1016/j.jns.2017.01.027
   PubMed Web of Science ®Google Scholar
• Sedlak TL, Chandavimol M, Straatman L. Cardiac transplantation: a temporary solution for Friedreich’s ataxia-induced dilated cardiomyopathy. J Heart Lung Transplant. 2004;23(11):1304–1306. doi:10.1016/j.healun.2003.09.015
   PubMed Web of Science ®Google Scholar
• Leonard H, Forsyth R. Friedreich’s ataxia presenting after cardiac transplantation. Arch Dis Child. 2001;84(2):167–168. doi:10.1136/adc.84.2.167
   Web of Science ®Google Scholar
• Yoon G, Soman T, Wilson J, et al. Cardiac transplantation in Friedreich ataxia. J Child Neurol. 2012;27(9):1193–1196. doi:10.1177/0883073812448229
   Web of Science ®Google Scholar
• Segovia J, Alonso-Pulpon L, Burgos R, et al. Heart transplantation in Friedreich’s ataxia and other neuromuscular diseases. J Heart Lung Transplant. 2001;20(2):169. doi:10.1016/S1053-2498(00)00313-2
   Google Scholar
• Mejia E, Lynch A, Hearle P, et al. Ectopic burden via holter monitors in Friedreich ataxia. Pediatr Neurol. 2021;117:29–33. doi:10.1016/j.pediatrneurol.2021.01.004
   PubMed Web of Science ®Google Scholar
• Coskun KO, Popov AF, Schmitto JD, et al. Feasibility of implantable cardioverter defibrillator treatment in five patients with familial Friedreich’s ataxia–a case series. Artif Organs. 2010;34(11):1061–1065. doi:10.1111/j.1525-1594.2010.01140.x
   Web of Science ®Google Scholar
• Zipse MM, Aleong RG. Acquired pulmonary vein isolation in a patient with Friedreich ataxia. Card Electrophysiol Clin. 2016;8(1):151–153. doi:10.1016/j.ccep.2015.10.016
   Google Scholar
• Postigo A, Datino T, Espinosa MA, Fernandez-Aviles F, Arenal A. Epicardial ablation for ventricular tachycardia in Freidreich’s ataxia cardiomyopathy. Europace. 2019;21(7):1095. doi:10.1093/europace/euz030
   Web of Science ®Google Scholar
• Brown E, Wilding JP, Alam U, Barber TM, Karalliedde J, Cuthbertson DJ. The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection. Ann Med. 2020;1–32. doi:10.1080/07853890.2020.1841281
   Web of Science ®Google Scholar
• Allard P, Dansereau J, Duhaime M, Geoffroy G. Scoliosis assessment in Friedreich’s ataxia by means of intrinsic parameters. Can J Neurol Sci. 1984;11(S4):582–587. doi:10.1017/S0317167100035095
   Web of Science ®Google Scholar
• Simon AL, Meyblum J, Roche B, et al. Scoliosis in patients with Friedreich ataxia: results of a consecutive prospective series. Spine Deform. 2019;7(5):812–821. doi:10.1016/j.jspd.2019.02.005
   Google Scholar
• Agámez Medina GL, Pantin EJ, Lorthé J, Therrien PJ. Anaesthesia for correction of scoliosis in pediatric patient with Friedreich’s ataxia. Rev Esp Anestesiol Reanim. 2015;62(1):42–45. doi:10.1016/j.redar.2014.03.001
   Google Scholar
• Corben LA, Lynch D, Pandolfo M, Schulz JB, Delatycki MB; Clinical Management Guidelines Writing Group. Consensus clinical management guidelines for Friedreich ataxia. Orphanet J Rare Dis. 2014;9:184. doi:10.1186/s13023-014-0184-7
   PubMed Web of Science ®Google Scholar
• Tsirikos AI, Smith G. Scoliosis in patients with Friedreich’s ataxia. J Bone Joint Surg Br. 2012;94(5):684–689. doi:10.1302/0301-620X.94B5.28391
   Google Scholar
• Milbrandt TA, Kunes JR, Karol LA. Friedreich’s ataxia and scoliosis: the experience at two institutions. J Pediatr Orthop. 2008;28(2):234–238. doi:10.1097/BPO.0b013e318164fa79
   Web of Science ®Google Scholar
• Pelosi L, Lamb J, Grevitt M, Mehdian SM, Webb JK, Blumhardt LD. Combined monitoring of motor and somatosensory evoked potentials in orthopaedic spinal surgery. Clin Neurophysiol. 2002;113(7):1082–1091. doi:10.1016/S1388-2457(02)00027-5
   PubMed Web of Science ®Google Scholar
• Lynch DR, Willi SM, Wilson RB, et al. A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial. Mov Disord. 2012;27(8):1026–1033. doi:10.1002/mds.25058
   PubMed Web of Science ®Google Scholar
• Cnop M, Mulder H, Igoillo-Esteve M. Diabetes in Friedreich ataxia. J Neurochem. 2013;126(Suppl 1):94–102. doi:10.1111/jnc.12216
   PubMed Web of Science ®Google Scholar
• McCormick A, Farmer J, Perlman S, et al. Impact of diabetes in the Friedreich ataxia clinical outcome measures study. Ann Clin Transl Neurol. 2017;4(9):622–631. doi:10.1002/acn3.439
   PubMed Web of Science ®Google Scholar
• Chakraborty PP, Ray S, Bhattacharjee R, et al. First presentation of diabetes as diabetic ketoacidosis in a case of Friedreich’s ataxia. Clin Diabetes. 2015;33(2):84–86. doi:10.2337/diaclin.33.2.84
   PubMedGoogle Scholar
• Pappa A, Hausler MG, Veigel A, et al. Diabetes mellitus in Friedreich ataxia: a case series of 19 patients from the German-Austrian diabetes mellitus registry. Diabetes Res Clin Pract. 2018;141:229–236.
   PubMed Web of Science ®Google Scholar
• Igoillo-Esteve M, Gurgul-Convey E, Hu A, et al. Unveiling a common mechanism of apoptosis in beta-cells and neurons in Friedreich’s ataxia. Hum Mol Genet. 2015;24(8):2274–2286. doi:10.1093/hmg/ddu745
   PubMed Web of Science ®Google Scholar
• Cnop M, Igoillo-Esteve M, Rai M, et al. Central role and mechanisms of beta-cell dysfunction and death in friedreich ataxia-associated diabetes. Ann Neurol. 2012;72(6):971–982. doi:10.1002/ana.23698
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15–S33. doi:10.2337/dc21-S002
   PubMed Web of Science ®Google Scholar
• Sharma R, Reinstadler B, Engelstad K, et al. Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity. JCI. 2021;131(2). doi:10.1172/JCI136055.
   Google Scholar
• American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S111–S24. doi:10.2337/dc21-S009
   PubMed Web of Science ®Google Scholar
• Yeung RO, Al Jundi M, Gubbi S, et al. Management of mitochondrial diabetes in the era of novel therapies. J Diabetes Complications. 2020;107584.
   Web of Science ®Google Scholar
• Igoillo-Esteve M, Oliveira AF, Cosentino C, et al. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia. JCI Insight. 2020;5(2):e134221. doi:10.1172/jci.insight.134221
   Web of Science ®Google Scholar
• Bamgboye AO, Oni IO, Collier A. Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review. Eur J Clin Pharmacol. 2020;77(5):651–657. doi:10.1007/s00228-020-03051-3
   Web of Science ®Google Scholar
• Wang T, Liu J, McDonald C, et al. GDF15 is a heart-derived hormone that regulates body growth. EMBO Mol Med. 2017;9(8):1150–1164. doi:10.15252/emmm.201707604
   Web of Science ®Google Scholar
• Greeley NR, Regner S, Willi S, Lynch DR. Cross-sectional analysis of glucose metabolism in Friedreich ataxia. J Neurol Sci. 2014;342(1–2):29–35. doi:10.1016/j.jns.2014.04.015
   PubMed Web of Science ®Google Scholar
• Weber DR. Bone health in childhood chronic disease. Endocrinol Metab Clin North Am. 2020;49(4):637–650. doi:10.1016/j.ecl.2020.07.002
   Web of Science ®Google Scholar
• Eigentler A, Nachbauer W, Donnemiller E, Poewe W, Gasser RW, Boesch S. Low bone mineral density in Friedreich ataxia. Cerebellum. 2014;13(5):549–557. doi:10.1007/s12311-014-0568-1
   Web of Science ®Google Scholar
• Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endo Met. 2012;97(6):1802–1822. doi:10.1210/jc.2011-3045
   PubMed Web of Science ®Google Scholar
• Force USPST; Curry SJ, Krist AH, Owens DK, et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2018;319(24):2521–2531. doi:10.1001/jama.2018.7498.
   Web of Science ®Google Scholar
• Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline. J Clin Endo Met. 2019;104(5):1595–1622. doi:10.1210/jc.2019-00221
   PubMed Web of Science ®Google Scholar
• Ward LM, Weber DR, Munns CF, Hogler W, Zemel BS, Contemporary A. View of the definition and diagnosis of osteoporosis in children and adolescents. The Journal of clinical endocrinology and metabolism. 2019. Management of primary and secondary osteoporosis in children. Ther Adv Musculoskelet Dis. 2020;12:1759720X20969262.
   Google Scholar
• Galindo-Zavala R, Bou-Torrent R, Magallares-Lopez B, et al. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children. Pediatr Rheumatol Online J. 2020;18(1):20. doi:10.1186/s12969-020-0411-9
   PubMed Web of Science ®Google Scholar
• Xiong E, Lynch AE, Corben LA, et al. Health related quality of life in Friedreich ataxia in a large heterogeneous cohort. J Neurol Sci. 2020;410:116642. doi:10.1016/j.jns.2019.116642
   PubMed Web of Science ®Google Scholar
• Nieto A, Hernández-Torres A, Pérez-Flores J, Montón F. Depressive symptoms in Friedreich ataxia. Int J Clin Health Psychol. 2018;18(1):18–26. doi:10.1016/j.ijchp.2017.11.004
   PubMed Web of Science ®Google Scholar
• Reetz K, Dogan I, Hohenfeld C, et al. Nonataxia symptoms in Friedreich ataxia: report from the registry of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS). Neurology. 2018;91(10):e917–e930. doi:10.1212/WNL.0000000000006121
   PubMed Web of Science ®Google Scholar
• Costabile T, Capretti V, Abate F, et al. Emotion recognition and psychological comorbidity in Friedreich’s ataxia. Cerebellum. 2018;17(3):336–345. doi:10.1007/s12311-018-0918-5
   PubMed Web of Science ®Google Scholar
• Sayah S, Rotgé JY, Francisque H, et al. Personality and neuropsychological profiles in Friedreich ataxia. Cerebellum. 2018;17(2):204–212. doi:10.1007/s12311-017-0890-5
   Web of Science ®Google Scholar
• Silva CB, Yasuda CL, D’Abreu A, Cendes F, Lopes-Cendes I, França MC. Neuroanatomical correlates of depression in Friedreich’s ataxia: a voxel-based morphometry study. Cerebellum. 2013;12(3):429–436. doi:10.1007/s12311-012-0424-0
   Web of Science ®Google Scholar
• Singh G, Binstadt BA, Black DF, Corr AP, Rummans TA. Electroconvulsive therapy and Friedreich’s ataxia. J ECT. 2001;17(1):53–54. doi:10.1097/00124509-200103000-00011
   Web of Science ®Google Scholar
• Casey DA. Electroconvulsive therapy and Friedreich’s ataxia. Convuls Ther. 1991;7(1):45–47.
   Google Scholar
• Flood MK, Perlman SL. The mental status of patients with Friedreich’s ataxia. J Neurosci Nurs. 1987;19(5):251–255. doi:10.1097/01376517-198710000-00006
   Google Scholar
• Pandolfo M, Montermini L. Prenatal diagnosis of Friedreich ataxia. Prenat Diagn. 1998;18(8):831–833. doi:10.1002/(SICI)1097-0223(199808)18:8<831::AID-PD437>3.0.CO;2-N
   Web of Science ®Google Scholar
• Delatycki MB, Tai G, Corben L, et al. HFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia. Mov Disord. 2014;29(7):940–943. doi:10.1002/mds.25795
   Web of Science ®Google Scholar
• Wilson RB, Lynch DR, Farmer JM, Brooks DG, Fischbeck KH. Increased serum transferrin receptor concentrations in Friedreich ataxia. Ann Neurol. 2000;47(5):659–661. doi:10.1002/1531-8249(200005)47:5<659::AID-ANA17>3.0.CO;2-T
   Web of Science ®Google Scholar
• Wilson RB, Lynch DR, Fischbeck KH. Normal serum iron and ferritin concentrations in patients with Friedreich’s ataxia. Ann Neurol. 1998;44(1):132–134. doi:10.1002/ana.410440121
   PubMed Web of Science ®Google Scholar
• Pandolfo M, Arpa J, Delatycki MB, et al. Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. Ann Neurol. 2014;76(4):509–521. doi:10.1002/ana.24248
   PubMed Web of Science ®Google Scholar
• Boddaert N, Le Quan Sang KH, Rötig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood. 2007;110(1):401–408. doi:10.1182/blood-2006-12-065433
   PubMed Web of Science ®Google Scholar
• Kakhlon O, Manning H, Breuer W, et al. Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation. Blood. 2008;112(13):5219–5227. doi:10.1182/blood-2008-06-161919
   PubMed Web of Science ®Google Scholar
• Shinnick JE, Schadt K, Strawser C, et al. Comorbid medical conditions in Friedreich Ataxia: association with inflammatory bowel disease and growth hormone deficiency. J Child Neurol. 2016;31(9):1161–1165. doi:10.1177/0883073816643408
   PubMed Web of Science ®Google Scholar
• Shinnick JE, Isaacs CJ, Vivaldi S, Schadt K, Lynch DR. Friedreich Ataxia and nephrotic syndrome: a series of two patients. BMC Neurol. 2016;16:3. doi:10.1186/s12883-016-0526-2
   PubMed Web of Science ®Google Scholar
• Schweiger B, Klingensmith GJ, Wadwa RP. Graves’ disease in a patient with Friedreich’s ataxia and diabetes mellitus. Curr Opin Pediatr. 2010;22(4):536–538. doi:10.1097/MOP.0b013e32833a4511
   Web of Science ®Google Scholar
• Snyder M, Seyer L, Lynch DR, Resnick A, Zesiewicz TA. Cardiac dysfunction exacerbated by endocrinopathies in Friedreich ataxia: a case series. J Child Neurol. 2012;27(10):1316–1319. doi:10.1177/0883073811435242
   Web of Science ®Google Scholar
• Deutsch EC, Seyer LA, Perlman SL, Yu J, Lynch DR. Clinical monitoring in a patient with Friedreich ataxia and osteogenic sarcoma. J Child Neurol. 2012;27(9):1159–1163. doi:10.1177/0883073812448460
   Web of Science ®Google Scholar
• Martelli A, Friedman LS, Reutenauer L, et al. Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich’s ataxia. Dis Model Mech. 2012;5(6):860–869. doi:10.1242/dmm.009829
   Web of Science ®Google Scholar
• Cherian D, Schadt K, Park C, Veasey S, Goldberg D, Lynch D. Coexistence of tyrosinemia and Friedreich ataxia in a single patient: treatment with liver transplantation. Ann Case Rep. 2021. doi:10.1093/ehjcr/ytaa553
   Google Scholar
• Aghajan Y, Yoon JM, Crawford JR. Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease. BMJ Case Rep. 2017;bcr2016218981. doi:10.1136/bcr-2016-218981
   Google Scholar
• Ichikawa M, Suzuki D, Inamoto J, et al. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease. J Pediatr Hematol Oncol. 2012;34(3):239–241. doi:10.1097/MPH.0b013e3182352cf5
   PubMed Web of Science ®Google Scholar
• Friedman LS, Paulsen EK, Schadt KA, et al. Pregnancy with Friedreich ataxia: a retrospective review of medical risks and psychosocial implications. Am J Obstet Gynecol. 2010;203(3):224.e1–5. doi:10.1016/j.ajog.2010.03.046
   Web of Science ®Google Scholar
• Bonnechère B, Jansen B, Haack I, et al. Automated functional upper limb evaluation of patients with Friedreich ataxia using serious games rehabilitation exercises. J Neuroeng Rehabil. 2018;15(1):87. doi:10.1186/s12984-018-0430-7
   Web of Science ®Google Scholar
• Portaro S, Russo M, Bramanti A, et al. The role of robotic gait training and tDCS in Friedrich ataxia rehabilitation: a case report. Medicine (Baltimore). 2019;98(8):e14447. doi:10.1097/MD.0000000000014447
   PubMed Web of Science ®Google Scholar
• Doğan-Aslan M, Büyükvural-şen S, Nakipoğlu-Yüzer GF, Özgirgin N. Demographic and clinical features and rehabilitation outcomes of patients with Friedreich ataxia: a retrospective study. Turk J Phys Med Rehabil. 2018;64(3):230–238. doi:10.5606/tftrd.2018.2213
   Web of Science ®Google Scholar
• Milne SC, Corben LA, Roberts M, et al. Can rehabilitation improve the health and well-being in Friedreich’s ataxia: a randomized controlled trial? Clin Rehabil. 2018;32(5):630–643. doi:10.1177/0269215517736903
   Web of Science ®Google Scholar
• Maring J, Croarkin E, Morgan S, Plack M. Perceived effectiveness and barriers to physical therapy services for families and children with Friedreich ataxia. Pediatr Phys Ther. 2013;25(3):305–313. doi:10.1097/PEP.0b013e31828ed7cb
   Web of Science ®Google Scholar
• Daker-White G, Greenfield J, Ealing J. “Six sessions is a drop in the ocean”: an exploratory study of neurological physiotherapy in idiopathic and inherited ataxias. Physiotherapy. 2013;99(4):335–340. doi:10.1016/j.physio.2013.02.001
   PubMed Web of Science ®Google Scholar
• Milne SC, Campagna EJ, Corben LA, et al. Retrospective study of the effects of inpatient rehabilitation on improving and maintaining functional independence in people with Friedreich ataxia. Arch Phys Med Rehabil. 2012;93(10):1860–1863. doi:10.1016/j.apmr.2012.03.026
   Web of Science ®Google Scholar
• Goulipian C, Bensoussan L, Viton JM, Milhe-de Bovis V, Ramon J, Delarque A. Orthopedic 5 shoes improve gait in Friedreich’s ataxia: a clinical and quantified case study. Eur. J Phys Rehabil Med. 2008;44(1):93–98.
   Web of Science ®Google Scholar
• Maring JR, Croarkin E. Presentation and progression of Friedreich ataxia and implications for physical therapist examination. Phys Ther. 2007;87(12):1687–1696. doi:10.2522/ptj.20060232
   Web of Science ®Google Scholar
• Delatycki MB, Holian A, Corben L, et al. Surgery for equinovarus deformity in Friedreich’s ataxia improves mobility and independence. Clin Orthop Relat Res. 2005;430:138–141. doi:10.1097/01.blo.0000150339.74041.0e
   Web of Science ®Google Scholar
• Isaacs CJ, Farmer JM, Schadt KA, et al. Geographic and socio-demographic features of Friedreich ataxia: implications for clinical research. J Rare Dis. 2016;4(1):34–43.
   Google Scholar